Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

Share Price is delayed by 15 minutes
Get Live Data
2.21    0.01 (0.45%)
Bid:
2.01
Ask:
2.19
Spread: 0.18 (8.955%)
Market Cap: £44.34m
QED Live PriceLast checked at - London Stock Exchange

Intraday Quadrise Share Chart

Valkor update

26 Sep 2025 07:00

RNS Number : 9845A
Quadrise PLC
26 September 2025
 

Certain of the information contained within this announcement is deemed by the Company to constitute inside information as stipulated under The Market Abuse Regulation (EU 596/2014) pursuant to the Market Abuse (Amendment) (EU Exit) Regulations 2018. Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

 

 

26 September 2025

 

Quadrise plc

("Quadrise", "QED" or the "Company")

 

Valkor update

 

Quadrise plc (AIM: QED), the technology company focused on the decarbonisation of shipping and heavy industry through deployment of low emission fuels and biofuels, confirms the signature of an addendum (the "Addendum") to the June 2023 Site License and Supply Agreement ("SLS Agreement") with Valkor Technologies LLC ("Valkor") in Utah, USA.

 

Pursuant to the Addendum, the payment of US$1.0 million due to the Company under the SLS Agreement (as amended) has been re-phased over the period to 30 June 2026, with the deliveries of Multifuel Manufacturing Units ("MMUs") and associated payments to the Company amended to match updated expectations of oil production ramp-up at the Valkor project site.

 

On 14 January 2025, an addendum to the SLS Agreement was executed by the Parties under which Valkor agreed to pay Quadrise an aggregate of US$1.5 million in exchange for the provision by Quadrise of an MSAR license and the delivery of a smaller Multifuel Manufacturing Unit ("MMU") in 2025 prior to the delivery of a full size MMU thereafter.

Due to slower than expected ramp-up in oil production and resulting financial constraints during the period, Quadrise and Valkor have now agreed a further addendum to the SLS Agreement as follows:

· A re-phased payment of the initial US$1.0m license fee, with a non-refundable amount of US$50k payable immediately, US$0.3 million payable by Valkor on or before 31 March 2026 and the remaining US$0.65 million due on 30 June 2026.

 

· The supply by Quadrise of a smaller Multifuel Manufacturing Unit ("MMU") of 600 bpd capacity on an interim basis by 30 June 2026, for which Valkor will pay US$0.2 million by 30 September 2026. A further US$0.3 million will be due to Quadrise upon supply of a full size 6,000 bpd MMU to Valkor, in exchange for the 600 bpd MMU.

 

· A project development and support services fee of US$75,000 payable quarterly by Valkor from 1 July 2026 for a minimum period of two years, in respect of Quadrise engineering and process design and commissioning services, site operations and compliance support.

 

Commenting on the update, Jason Miles, Chief Technology Officer of Quadrise, said:

 

"We are pleased to have signed this addendum with Valkor, which reflects their continued commitment to deploying Quadrise technology in Utah as a route to market for their heavy sweet oil, whilst also re-organising licence and MMU delivery payments to be received by the Company."

 

"When combined, our respective technologies will provide very attractive low sulphur fuels and biofuels with compelling economics and environmental credentials."

 

Steven Byle, Chief Executive Officer of Valkor, added:

 

"While progress during 2025 has been slower than anticipated, we remain committed to our partnership with Quadrise and to deployment of their technology in Utah.

 

The recent approvals and financing secured for our first mined oil sands marked a significant milestone and we are now focused on increasing oil production and enhancing product quality.

 

Quadrise technology remains a key part of our strategy to unlock higher value markets for our heavy sweet oils and we look forward to working closely with the team to bring these solutions to market."

 

For further information please contact:

 

Quadrise Plc

+44 (0)20 7031 7321

Andy Morrison, Chairman

Jason Miles, Chief Technology Officer

 

 

Nominated Adviser

Cavendish Capital Markets Limited

 

 

+44 (0)20 7220 0500

Ben Jeynes

Katy Birkin

George Lawson

 

Joint Brokers

Shore Capital Stockbrokers Limited

 

 

+44 (0)20 7408 4090

Toby Gibbs, Harry Davies-Ball (Corporate Advisory)

Fiona Conroy (Corporate Broking)

 

VSA Capital Limited

Andrew Raca (Corporate Finance)

Andrew Monk (Corporate Broking)

 

 

+44 (0)20 3005 5000

 

Public & Investor Relations

 

 

Tavistock Communications (Financial PR & IR)

Simon Hudson

Nick Elwes

Ruairi Millar

 

+44 (0) 20 7920 3150

 

 BLUE Communications Limited (Marine & Trade PR)

 Rhys Thomas

 Sam Deacon

 

 

 

+44 (0)7595 227750

+44 (0)7527 558846

 

 

 

 

About Quadrise

Quadrise is the supplier of MSAR® and bioMSAR™ emulsion technology, fuels and biofuels, providing innovative solutions to lower energy costs, pollution and greenhouse gas emissions today for the global power generation, shipping, industrial and oil industries.

Learn more at: www.quadrise.com

 

Follow us on social media:

LinkedIn: @Quadrise Plc

X: @QuadrisePlc

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEQLBLEKLLBBX
Date   Source Headline
9th Jun 20144:30 pmRNSDirector/PDMR Shareholding
3rd Jun 20144:30 pmRNSDirector/PDMR Shareholding
3rd Jun 20144:30 pmRNSTotal Voting Rights
2nd Jun 20144:31 pmRNSBlocklisting Interim Review
2nd Jun 20144:30 pmRNSHolding(s) in Company
28th May 20144:30 pmRNSHolding(s) in Company
28th May 20144:29 pmRNSAdditional Listing
27th May 20144:30 pmRNSDirector/PDMR Shareholding
23rd May 20147:00 amRNSFinal Results for the year ended 31 March 2014
16th May 20147:00 amRNSDisposal of share in iQ JV to Wellcome Trust
8th May 20149:01 amRNSNotice of Results
7th May 20144:30 pmRNSDirector/PDMR Shareholding
2nd May 20144:01 pmRNSTotal Voting Rights
2nd May 20144:00 pmRNSDirector/PDMR Shareholding
1st May 20147:00 amRNSQuintain acquires Aldermary House, EC4
14th Apr 20147:00 amRNSRe Joint Venture at Wembley Park
11th Apr 20144:38 pmRNSHolding(s) in Company
9th Apr 20144:31 pmRNSReplacement Director/PDMR Shareholding
2nd Apr 20144:31 pmRNSTotal Voting Rights
2nd Apr 20144:30 pmRNSDirector/PDMR Shareholding
26th Mar 20144:30 pmRNSHolding(s) in Company
26th Mar 20143:00 pmRNSDirector Declaration
11th Mar 20149:03 amRNSDirector/PDMR Shareholding
4th Mar 20144:31 pmRNSTotal Voting Rights
4th Mar 20144:30 pmRNSDirector/PDMR Shareholding
14th Feb 20145:17 pmRNSHolding(s) in Company
12th Feb 20144:30 pmRNSHolding(s) in Company
12th Feb 20147:00 amRNSDisposal of interest in Mitre Passage
12th Feb 20147:00 amRNSInterim Management Statement
7th Feb 20147:00 amRNSQuintain acquires Kingsbourne House
4th Feb 20144:31 pmRNSTotal Voting Rights
4th Feb 20144:28 pmRNSDirector/PDMR Shareholding
30th Jan 20144:30 pmRNSDirector/PDMR Shareholding
7th Jan 20144:32 pmRNSBlocklisting Interim Review
7th Jan 20144:31 pmRNSBlocklisting Interim Review
7th Jan 20144:30 pmRNSDirector/PDMR Shareholding
7th Jan 20144:30 pmRNSDirector/PDMR Shareholding
7th Jan 20144:30 pmRNSTotal Voting Rights
27th Dec 20139:43 amRNSHolding(s) in Company
10th Dec 20139:30 amRNSDirector/PDMR Shareholding
5th Dec 20131:05 pmRNSHolding(s) in Company
3rd Dec 20139:30 amRNSHolding(s) in Company
3rd Dec 20139:06 amRNSTotal Voting Rights
3rd Dec 20139:05 amRNSDirector/PDMR Shareholding
25th Nov 20137:00 amRNSResults for the six months ended 30 September 2013
21st Nov 20131:15 pmRNSGeneral Meeting voting results
8th Nov 20134:00 pmRNSNotice of Interim Results
7th Nov 20134:30 pmRNSDirector/PDMR Shareholding
7th Nov 201311:00 amRNSHolding(s) in Company
6th Nov 20139:00 amRNSChange in Director's details

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.